Taiwan S.E.
23:00:00 27/05/2024 BST
5-day change
1st Jan Change
28.5
TWD
+1.42%
-2.90%
+7.95%
ScinoPharm Taiwan, Ltd. Announces Demise of Cheng Kao-Huei, Chairman and Chief Strategy Officer
August 14, 2017 at 10:54 am
ScinoPharm Taiwan, Ltd. announced the demise of Mr. Cheng Kao-Huei, chairman and chief strategy officer.
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
05-10
CI
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
02-26
CI
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
11-07
CI
ScinoPharm Taiwan, Ltd. Announces Executive Changes
11-03
CI
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
07/08/23
CI
ScinoPharm Taiwan, Ltd. Announces Compensation Committee Appointments
29/05/23
CI
ScinoPharm Taiwan, Ltd. Announces Independent Director Appointments
29/05/23
CI
ScinoPharm Taiwan, Ltd. Approves Cash Dividend for 2022, Payable on July 28, 2023
29/05/23
CI
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
11/05/23
CI
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
01/03/23
CI
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
08/11/22
CI
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
05/08/22
CI
Scinopharm Taiwan, Ltd Approves Cash Dividend, Payable August 2, 2022
30/05/22
CI
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
06/05/22
CI
ScinoPharm Taiwan, Ltd Announces Executive Changes
06/05/22
CI
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
25/02/22
CI
ScinoPharm Taiwan, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
09/11/21
CI
Scinopharm Taiwan, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
10/08/21
CI
ScinoPharm Taiwan, Ltd. Announces Cash Dividend, Payable on September 23, 2021
10/08/21
CI
Scinopharm Taiwan, Ltd. Approves to Distribute Cash Dividend
21/07/21
CI
ScinoPharm Taiwan, Ltd. Appoints Chih-Hui Lin as Corporate Governance Officer
11/05/21
CI
Scinopharm Taiwan, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
10/05/21
CI
Scinopharm Taiwan, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
23/03/21
CI
Scinopharm Taiwan, Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
05/11/20
CI
Scinopharm Taiwan, Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
12/08/20
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
ScinoPharm Taiwan Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of active pharmaceutical ingredients. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The Company is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.
More about the company
Last Close Price
28.5
TWD
Average target price
26
TWD
Spread / Average Target
-8.77%
Consensus
1st Jan change
Capi.
+7.95% 690M +37.62% 727B -7.87% 354B +15.66% 328B -0.38% 277B +13.47% 243B +7.35% 205B -6.42% 203B +3.90% 164B -2.07% 164B
Other Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
SCINOPHARM TAIWAN, LTD. 
